Andra AP fonden Trims Holdings in Molina Healthcare, Inc $MOH

Andra AP fonden cut its stake in Molina Healthcare, Inc (NYSE:MOH) by 81.3% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 11,284 shares of the company’s stock after selling 49,216 shares during the quarter. Andra AP fonden’s holdings in Molina Healthcare were worth $2,159,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in MOH. Choreo LLC boosted its position in shares of Molina Healthcare by 176.0% in the 3rd quarter. Choreo LLC now owns 2,752 shares of the company’s stock worth $527,000 after purchasing an additional 1,755 shares in the last quarter. Westpac Banking Corp boosted its holdings in shares of Molina Healthcare by 247.0% during the 3rd quarter. Westpac Banking Corp now owns 9,557 shares of the company’s stock valued at $1,829,000 after acquiring an additional 6,803 shares during the last quarter. Amitell Capital Pte Ltd bought a new stake in shares of Molina Healthcare in the third quarter worth $7,290,000. Intech Investment Management LLC lifted its stake in shares of Molina Healthcare by 78.9% in the 3rd quarter. Intech Investment Management LLC now owns 33,623 shares of the company’s stock worth $6,434,000 after purchasing an additional 14,826 shares during the period. Finally, Waddell & Associates LLC bought a new stake in shares of Molina Healthcare during the 3rd quarter valued at $566,000. Hedge funds and other institutional investors own 98.50% of the company’s stock.

Molina Healthcare Stock Performance

NYSE:MOH opened at $154.54 on Friday. The firm has a market capitalization of $7.96 billion, a PE ratio of 18.05 and a beta of 0.49. The stock’s fifty day moving average is $167.85 and its 200 day moving average is $168.72. Molina Healthcare, Inc has a fifty-two week low of $121.06 and a fifty-two week high of $359.97. The company has a debt-to-equity ratio of 0.97, a quick ratio of 1.69 and a current ratio of 1.69.

Molina Healthcare (NYSE:MOH) last announced its earnings results on Thursday, February 5th. The company reported ($2.75) earnings per share for the quarter, missing the consensus estimate of $0.43 by ($3.18). Molina Healthcare had a net margin of 1.04% and a return on equity of 13.60%. The firm had revenue of $11.38 billion during the quarter, compared to analysts’ expectations of $10.90 billion. During the same period in the prior year, the company posted $5.05 EPS. The company’s revenue was up 8.3% compared to the same quarter last year. Molina Healthcare has set its FY 2026 guidance at 5.000- EPS. On average, sell-side analysts anticipate that Molina Healthcare, Inc will post 24.4 earnings per share for the current year.

Analysts Set New Price Targets

A number of brokerages recently issued reports on MOH. TD Cowen cut their price objective on Molina Healthcare from $175.00 to $144.00 and set a “hold” rating for the company in a research note on Monday, February 9th. Sanford C. Bernstein restated an “outperform” rating and set a $224.00 target price on shares of Molina Healthcare in a research note on Tuesday, January 6th. Truist Financial decreased their price target on Molina Healthcare from $190.00 to $145.00 and set a “hold” rating on the stock in a report on Tuesday, February 17th. Weiss Ratings reiterated a “sell (d+)” rating on shares of Molina Healthcare in a research report on Thursday, January 22nd. Finally, UBS Group reissued a “neutral” rating and issued a $145.00 price target on shares of Molina Healthcare in a report on Monday, February 9th. Two investment analysts have rated the stock with a Buy rating, ten have issued a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $157.86.

Trending Headlines about Molina Healthcare

Here are the key news stories impacting Molina Healthcare this week:

• Positive Sentiment: Zacks raised its Q3 2027 EPS estimate for MOH to $1.83 from $0.93, a notable upward revision that could be read as an improving outlook for that quarter. Zacks Q3 2027 raise
• Neutral Sentiment: Zacks published an FY2028 estimate of $12.32 EPS — a new forward-year datapoint investors may use to recalibrate multi‑year models, but it’s not directly comparable to the immediate near‑term cuts. Zacks FY2028 estimate
• Negative Sentiment: Widespread downgrades to 2026 and 2027 guidance: Zacks sharply cut FY2026 EPS to $5.06 (from $13.97) and FY2027 to $7.61 (from $18.88), and reduced many quarterly estimates (e.g., Q1–Q4 2026 and Q1–Q2 2027 were trimmed substantially). These large downward revisions signal weaker near‑term earnings expectations and are the primary negative driver for the stock. Zacks broad cuts
• Negative Sentiment: Notable single-quarter cuts: Q2 2027 was lowered to $1.98 from $6.97, Q1 2027 to $1.57 from $6.72, Q2 2026 to $1.68 from $4.09, and Q4 2026 to $0.82 from $2.93 — these steep cuts increase the risk of further negative surprises relative to prior expectations. Zacks quarter cuts

Molina Healthcare Company Profile

Molina Healthcare, Inc is a managed care company specializing in government-sponsored health insurance programs. The company offers Medicaid managed care plans, Medicare Advantage and prescription drug plans, and individual Marketplace plans under the Affordable Care Act. Through an integrated care model, Molina emphasizes preventive and primary care services, care coordination, and disease management to improve health outcomes for its members.

The company traces its roots to the early 1980s, when Dr.